Intomics is a privately owned biotechnology company spun out from the Center for Biological Sequence Analysis, Technical University of Denmark in 2008 to provide state-of-the-art solutions within biological data analysis to proprietary data for the pharmaceutical and biotechnology industry. Intomics is based in Lyngby, Denmark

The overall management of Intomics is governed by the Board of Directors, which members have extensive experience in Life Science industries, general management, financing and strategy. The daily operation is the responsibility of the Executive Management and the Scientific Advisory Board provides valuable input to the scientific strategy of Intomics.

Board of directors
The Board of Directors consists of Jón Ingi Benendiktsson (Chairman), Jens L. Hansen and Søren Brunak.
>> more

Management
Intomics is headed by CEO Thomas S. Jensen.
>>more

Scientific advisory board
The Scientific Advisory Board provides scientific input to Intomics and is key in enabling Intomics in offering state-of-the-art solutions to its customers. The board includes Professor Lars Juhl Jensen, Professor Søren Brunak, Dr. Niclas Tue Hansen and Dr. Kasper Lage.
>> more

Careers
Working at Intomics means working with experts providing customized solutions to complicated challenges. We hire employees with unique skills and qualification. A career in Intomics will take you far and push your skills to the limit.
>> more